LFVN Form 4: CEO Fife Vested PRSUs Converted and Sold 98,177 Shares

Q: What transactions did Steven R. Fife report on the Form 4 for LFVN?

Answer: He reported conversion of 90,718 and 108,960 PRSUs into common stock (acquired at $0) and a disposition of 98,177 shares sold at $13.10 on 08/31/2025.

Q: What were the grant dates for the PRSUs that vested for LFVN's CEO?

Answer: The PRSUs were granted on 08/24/2023 and 08/26/2024 and converted one-for-one into common stock.

Q: How many shares did Steven R. Fife beneficially own after the reported transactions?

Answer: The Form 4 shows beneficial ownership figures of 750,218 , 859,178 , and 761,001 following the respective reported transactions.

Q: Was the Form 4 signed and who signed it?

Answer: The form was signed by Alissa Neufeld, Power of Attorney for Steven R. Fife on 09/03/2025.

Q: Do the PRSUs convert at cost to the reporting person?

Answer: Yes; the PRSUs convert into common stock on a one-for-one basis and were reported as acquired at $0 .

[Form 4] Lifevantage Corporation Insider Trading Activity

Filing Impact

(High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Steven R. Fife, President and CEO and director of Lifevantage Corp (LFVN), reported insider transactions on 08/31/2025. Two tranches of previously granted performance restricted stock units converted into common stock: 90,718 shares (granted 08/24/2023) and 108,960 shares (granted 08/26/2024). Those PRSUs convert one-for-one into common shares and were reported as acquired at $0 under Rule 16 reporting codes. Separately, 98,177 shares were disposed of at a reported price of $13.10, leaving the reporting person with 761,001 and 859,178 total shares following the respective transactions as shown on the form.

Positive

Vested PRSUs converted one-for-one into common shares, reflecting compensation realization rather than external purchase
Substantial remaining insider ownership after transactions (reported beneficial ownership figures remain high)

Negative

Insider sale of 98,177 shares at $13.10 could be perceived as insider liquidity or diversification without stated context
Form does not state whether the sale was executed pursuant to a pre-established trading plan (Rule 10b5-1)

Insights

TL;DR: Insider received vested PRSUs that converted to shares and executed a significant sale; overall disclosure is routine.

These filings show time- and performance-based PRSUs vesting and converting one-for-one into common stock, which is common compensation for executives and not an open-market purchase. The sale of 98,177 shares at $13.10 is material in size but not accompanied by explanation (e.g., liquidity needs, diversification, or pre-arranged trading plan). Combined activity increases reported insider liquidity while leaving the CEO with substantial residual holdings, consistent with executive compensation realization rather than a change in control or strategy.

TL;DR: Disclosure aligns with standard Form 4 practice; PRSU vesting and a concurrent share sale are properly reported.

The Form 4 discloses grants from 2023 and 2024 that vested and converted into common stock, and a contemporaneous disposition. Reporting includes dates, quantities, and prices as required. There is no indication within the form of Rule 10b5-1 reliance or other trading-plan notation, and the filing was signed by a power of attorney. For governance review, the transactions are transparent but lack context on whether the sale was pre-planned.

09/03/2025 - 09:48 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fife Steven R

(Last)

(First)

(Middle)

3300 NORTH TRIUMPH BLVD #700

(Street)

LEHI

84043

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Lifevantage Corp [ LFVN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
08/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	08/31/2025		M		90,718⁽¹⁾	A	$0	750,218	D
Common Stock	08/31/2025		M		108,960⁽²⁾	A	$0	859,178	D
Common Stock	08/31/2025		F		98,177	D	$13.1	761,001	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Performance Stock Units	⁽³⁾	08/31/2025		M			90,718	⁽¹⁾	⁽¹⁾	Common Stock	90,718	$0	30,239	D
Performance Restricted Stock Units	⁽³⁾	08/31/2025		M			108,960	⁽²⁾	⁽²⁾	Common Stock	108,960	$0	54,479	D

Explanation of Responses:

1. On August 24, 2023, the reporting person was granted Performance Restricted Stock Units ("PRSUs") which vest upon achievement of previously established time-based and financial performance criteria.

2. On August 26, 2024, the reporting person was granted PRSUs which vest upon achievement of previously established time-based and financial performance criteria.

3. PRSUs convert into common stock on a one-for-one basis.

Remarks:

	/s/ Alissa Neufeld, Power of Attorney for Steven R. Fife	09/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

What transactions did Steven R. Fife report on the Form 4 for LFVN?

Answer: He reported conversion of 90,718 and 108,960 PRSUs into common stock (acquired at $0) and a disposition of 98,177 shares sold at $13.10 on 08/31/2025.

What were the grant dates for the PRSUs that vested for LFVN's CEO?

Answer: The PRSUs were granted on 08/24/2023 and 08/26/2024 and converted one-for-one into common stock.

How many shares did Steven R. Fife beneficially own after the reported transactions?

Answer: The Form 4 shows beneficial ownership figures of 750,218, 859,178, and 761,001 following the respective reported transactions.

Was the Form 4 signed and who signed it?

Answer: The form was signed by Alissa Neufeld, Power of Attorney for Steven R. Fife on 09/03/2025.

Do the PRSUs convert at cost to the reporting person?

Answer: Yes; the PRSUs convert into common stock on a one-for-one basis and were reported as acquired at $0.

AG真人官方

[Form 4] Lifevantage Corporation Insider Trading Activity

Insights

FAQ

What transactions did Steven R. Fife report on the Form 4 for LFVN?

What were the grant dates for the PRSUs that vested for LFVN's CEO?

How many shares did Steven R. Fife beneficially own after the reported transactions?

Was the Form 4 signed and who signed it?

Do the PRSUs convert at cost to the reporting person?

NASDAQ:LFVN

LFVN Rankings

LFVN Latest News

LFVN Latest SEC Filings

LFVN Stock Data

AG真人官方

Trending News

[Form 4] Lifevantage Corporation Insider Trading Activity

Insights

Securities Analyst neutral

Corporate Governance Expert neutral

FAQ

What transactions did Steven R. Fife report on the Form 4 for LFVN?

What were the grant dates for the PRSUs that vested for LFVN's CEO?

How many shares did Steven R. Fife beneficially own after the reported transactions?

Was the Form 4 signed and who signed it?

Do the PRSUs convert at cost to the reporting person?

NASDAQ:LFVN

LFVN Rankings

LFVN Latest News

LFVN Latest SEC Filings

LFVN Stock Data